| Target Price | $293.76 |
| Price | $292.59 |
| Potential | 0.40% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target Marriott 2026 . The average Marriott target price is $293.76. This is 0.40% higher than the current stock price. The highest price target is $348.60 19.14% , the lowest is $217.15 25.78% . | |
| A rating was issued by 31 analysts: 14 Analysts recommend Marriott to buy, 16 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Marriott stock has an average upside potential 2026 of 0.40% . Most analysts recommend the Marriott stock at Hold. |
27 Analysts have issued a sales forecast Marriott 2025 . The average Marriott sales estimate is $26.5b . This is 2.21% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $28.6b 10.18% , the lowest is $25.3b 2.41% .
This results in the following potential growth metrics:
| 2024 | $25.1b | 5.85% |
|---|---|---|
| 2025 | $26.5b | 5.57% |
| 2026 | $28.0b | 5.57% |
| 2027 | $29.6b | 5.72% |
| 2028 | $29.8b | 0.91% |
| 2029 | $30.7b | 2.79% |
| 2030 | $33.3b | 8.46% |
| 2031 | $34.1b | 2.53% |
| 2032 | $35.4b | 3.82% |
27 Analysts have issued an Marriott EBITDA forecast 2025. The average Marriott EBITDA estimate is $5.4b . This is 24.63% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.7b 30.46% , the lowest is $5.2b 20.36% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $4.0b | 2.09% |
|---|---|---|
| 2025 | $5.4b | 34.22% |
| 2026 | $5.8b | 6.59% |
| 2027 | $6.2b | 7.15% |
| 2028 | $7.0b | 14.08% |
| 2029 | $7.5b | 6.36% |
| 2030 | $7.9b | 5.35% |
| 2031 | $8.2b | 4.32% |
| 2032 | $8.6b | 4.99% |
| 2024 | 16.04% | 7.50% |
|---|---|---|
| 2025 | 20.40% | 27.15% |
| 2026 | 20.59% | 0.93% |
| 2027 | 20.87% | 1.36% |
| 2028 | 23.60% | 13.08% |
| 2029 | 24.41% | 3.43% |
| 2030 | 23.72% | 2.83% |
| 2031 | 24.13% | 1.73% |
| 2032 | 24.40% | 1.12% |
30 Marriott Analysts have issued a net profit forecast 2025. The average Marriott net profit estimate is $2.7b . This is 5.17% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 17.44% , the lowest is $2.6b 0.91% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $2.4b | 22.96% |
|---|---|---|
| 2025 | $2.7b | 15.62% |
| 2026 | $3.1b | 12.30% |
| 2027 | $3.4b | 11.70% |
| 2028 | $4.3b | 23.55% |
| 2029 | $4.8b | 12.72% |
| 2030 | $5.1b | 6.13% |
| 2031 | $5.5b | 7.22% |
| 2032 | $6.0b | 9.22% |
| 2024 | 9.46% | 27.22% |
|---|---|---|
| 2025 | 10.36% | 9.49% |
| 2026 | 11.02% | 6.37% |
| 2027 | 11.65% | 5.72% |
| 2028 | 14.26% | 22.40% |
| 2029 | 15.64% | 9.68% |
| 2030 | 15.30% | 2.17% |
| 2031 | 16.00% | 4.58% |
| 2032 | 16.83% | 5.19% |
30 Analysts have issued a Marriott forecast for earnings per share. The average Marriott EPS is $10.19 . This is 6.37% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.38 18.79% , the lowest is $9.78 2.09% .
This results in the following potential growth metrics and future valuations:
| 2024 | $8.33 | 18.17% |
|---|---|---|
| 2025 | $10.19 | 22.33% |
| 2026 | $11.45 | 12.37% |
| 2027 | $12.79 | 11.70% |
| 2028 | $15.80 | 23.53% |
| 2029 | $17.81 | 12.72% |
| 2030 | $18.90 | 6.12% |
| 2031 | $20.26 | 7.20% |
| 2032 | $22.13 | 9.23% |
| Current | 30.54 | 3.54% |
|---|---|---|
| 2025 | 28.71 | 6.00% |
| 2026 | 25.56 | 10.97% |
| 2027 | 22.88 | 10.49% |
| 2028 | 18.52 | 19.06% |
| 2029 | 16.43 | 11.29% |
| 2030 | 15.48 | 5.78% |
| 2031 | 14.44 | 6.72% |
| 2032 | 13.22 | 8.45% |
Based on analysts' sales estimates for 2025, the Marriott stock is valued at an EV/Sales of 3.54 and an P/S ratio of 2.96 .
This results in the following potential growth metrics and future valuations:
| Current | 3.62 | 4.23% |
|---|---|---|
| 2025 | 3.54 | 2.17% |
| 2026 | 3.35 | 5.28% |
| 2027 | 3.17 | 5.41% |
| 2028 | 3.14 | 0.90% |
| 2029 | 3.06 | 2.72% |
| 2030 | 2.82 | 7.80% |
| 2031 | 2.75 | 2.47% |
| 2032 | 2.65 | 3.68% |
| Current | 3.03 | 6.63% |
|---|---|---|
| 2025 | 2.96 | 2.16% |
| 2026 | 2.81 | 5.27% |
| 2027 | 2.65 | 5.42% |
| 2028 | 2.63 | 0.90% |
| 2029 | 2.56 | 2.72% |
| 2030 | 2.36 | 7.80% |
| 2031 | 2.30 | 2.47% |
| 2032 | 2.22 | 3.68% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Hold
➜
Hold
|
Unchanged | Dec 04 2025 |
| Wells Fargo |
➜
Overweight
|
Initiated | Nov 18 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Nov 05 2025 |
| BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Nov 05 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2025 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Oct 21 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Dec 04 2025 |
|
Initiated
Wells Fargo:
➜
Overweight
|
Nov 18 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Nov 05 2025 |
|
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Nov 05 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 22 2025 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Oct 21 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


